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1. Introduction 
Recent work by Pestka and Hintikka [I] and 
Pestka [2] on the effect of inhibitors of ribosomal 
function on the puromycin-dependent release of 
nascent peptides from bacterial polysomes has reveal- 
ed substantial differences in the action of these inhi- 
bitors on salt-washed ribosomes, polysomes and in- 
tact cells. In particular, the peptidyl transferase ac- 
ceptor site of polysomes has a one hundred-fold 
greater affinity for puromycin than that of salt- 
washed ribosomes [2,3]. In view of these important 
observations, we have now extended our substrate 
specificity studies with puromycin analogues [4, 5, 
71 to the acceptor site of E. coli polysomes to exam- 
ine the generality of this enhanced affinity. 
This work forms part of a wider investigation [4, 
.5,7-l I] of ribosomal peptidyl transferase, and the 
action of antibiotic inhibitors on this enzyme, by use 
of analogues and derivatives of puromycin as low 
molecular weight structural analogues of the 3’-ter- 
minus of aminoacyl-tRNA. 
2. Materials and methods 
2.1. Materials 
Lysozyme (Grade I) was obtained from Sigma 
* To whom correspondence should be sent. 
** Abbreviations: Pan, puromycin aminonucleoside; Pan-L- 
amino acid, 3’-N-L-aminoacyl-Pan; pPan-L-Phe, 5’-O-phos- 
phoryl-Pan-L-Phe; ApPan-Gly, 5’0adenylyl-Pan-Gly; all 
other analogues are abbreviated similarly. 
Definition: A’-site of peptidyl transferase, that part of the 
ribosomal acceptor or A-site which is in the active centre of 
peptidyl transferase [ 8.91. 
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Chemical Co.; Brij 58 from Atlas Chemical Industries, 
Delaware; puromfcin dihydrochloride from Nutri- 
tional Biochemicals Corporation, and [3H] puromy- 
tin (specific activity, 2.0 Ci/mmol) from the Radio- 
chemical Centre, Amersham. The 3’-N-aminoacyl and 
5’-0-nucleotidyl analogues of puromycin were pre- 
pared by methods described [lo] . 
2.2. Methods 
Polysomes were prepared from rapidly growing 
cultures of E. coli MRE600 by a minor modification 
of the lysozyme-Brij 58 lysis procedure of Pestka and 
Hintikka [ I] and were stored in liquid nitrogen. One 
minute peptidyl- [3 H] puromycin release assays were 
done essentially as described by Pestka [3], except 
that in some cases the solution also contained 30% 
(v/v) methanol and was slightly turbid. The time 
course of the assay was linear up to at least 1 .O min 
over the concentration ranges of [3H] puromycin and 
unlabelled puromycin analogues employed (see table 
1). 
The pepticyl transferase activity of high-salt- 
washed E. coli MRE 600 ribosomes was assayed by 
means of the fragment reaction as described by Harris 
et al. [ll] _ 
3. Results and discussion 
Since the 15 puromycin analogues used here were 
not available in radioactive form, the only feasible 
method of testing them for acceptor substrate speci- 
ficity in the polysome system was to use these analo- 
gues as competitive inhibitors of the formation of 
polypeptidyl-[3H] puromycin. Analysis of the veloc- 
ity inhibition data by means of Dixon plots [ 121 has 
North-Holland Publishing Company - Amsterdam 
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Table 1 
Inhibition constants for puromycin analogues in the release of peptidyl-[ 3H] puromycin from E. coli polysomes 
Analogue Ki(tiM)’ KiIKm3 Concentration 
range (M) 
Pan-Gly 2200 710 0.5-2.3 x 1O-3 
Pan-L-Leu 200 65 1.0-4.3 x 1o-4 
Pan-L-Tyr 3.3 1.1 2.7-11 x lo-’ 
Pan-L-Phe 2.8 0.9 1.9-8.0 X 1O-6 
Puromycin 3.12 1.0 0.2-5.0 X lo+ 
Pan-O-benzyl-L-Ser 29 9.4 2.0-8.2 x 10W5 
Pan-im-benzyl-L-His 540 170 0.9-3.9 x 1o-4 
Pan-L-Trp 1400 450 2.4-9.8 x 1O-4 
Pan-L-Lys 270 87 0.3-1.4 x 1o-4 
Pan-L-Pro 4000 1300 0.5-1.9 x 1o-4 
Pan-Gly 2200 710 0.5-2.3 x 1O-3 
ApPan-Gly 1600 520 1.4-5.8 X 1O-4 
GpPan-Gly 1200 390 2.1-8.6 X lo-’ 
UpPan-Gly 830 270 1.4-5.8 x 1O-4 
CpPan-Gly 61 20 1.8-7.4 x lo-’ 
CpPan-L-Phe 1.7 0.55 1,2-5.0 x 1O-6 
pPan- L- Phe 11 3.5 2.7-11 x lo-’ 
Pan-L-Phe 2.8 0.9 1.9-8.0 x 10W6 
’ Determined with [3H] puromycin as substrate at 0.5 and 5.0 bM. The probable errors computed during least squares fitting of 
Dizon plots [ 121 are within the range f 10%. All data were obtained with the same batch of polysomes. 
2 Substrate Michaelis constant, K m, computed from double reciprocal plot. 
3 The ratio of Ki of each analogue to the Km of puromycin. 
given apparent Ki values for each analogue which are 
a measure of the relative affinities of these analogues 
for the Al-site [8,9] of polysomal peptidyl trans- 
ferase. Although the equations of the Dixon plot are 
derived for an enzyme system which obeys Michaelis- 
Menten kinetics, such equations can, in practice, 
be used with peptidyl transferase to analyse the two- 
step puromycin reaction of binding followed by catal- 
ysis [I, 2, 131. 
The apparent Ki values in the E. coli peptidyl- 
[3 H] puromycin release assay for the 15 puromycin 
analogues are listed in table 1. These data provide, for 
the first time, a quantitative measure of the contribu- 
tion made to aminoacyl-tRNA binding by various 
parts of the peptidyl transferase A’-site. The role of 
the amino acid side chain is demonstrated by the nine 
3’-N-aminoacyl analogues. The series of natural amino 
acids with uncharged side chains confirms the earlier 
qualitative observations [4-7, 141 that a larger, and 
hence more hydrophobic [ 151 side chain gives rise to 
better binding (smaller Ki), up to a maximum repre- 
sented by puromycin. This natural antibiotic has 
presumably evolved to fit optimally into a hydro- 
phobic pocket [7-91 on the ribosome; steric repul- 
sion then may explain the weaker binding of the 
larger hydrophobic analogues, Pan-O-benzyl-L-ser, 
Pan-im-benzyl-L-His and Pan-L-Trp. The dual hydro- 
phobic-hydrophilic nature of the positively charged 
lysyl side-chain, and the rigid conformation of pro- 
line, may mean that these two analogues do not con- 
form to the simple hydrophobic model. A very simi- 
lar model has been proposed to explain the donor 
specificity of peptidyl trnasferase [ 161. 
Of the four Pan-Gly derivatives substituted on the 
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5’-hydroxyl, only CpPan-Gly showed a marked reduc- 
tion in Ki relative to that of Pan-Gly. The results are 
consistent with a binding site on the A’-site of pep- 
tidy1 transferase which is specific for the penultimate 
3’-CMP residue of transfer RNA as suggested pre- 
viously [S, 7-91 ; covalent affinity labelling experi- 
ments [l l] support the hypothesis that such specifici- 
ty could arise by conventional base-pairing with the 
ribosomal RNA. When the glycyl residue of CpPan- 
Gly was replaced by L-Phe, there was a marked reduc- 
tion in the Ki value to less than the Km of puromy- 
tin, a result which reflects the dominating effect of 
the proposed hydrophobic binding site occupied by 
the benzene ring of phenylalanine [S, 7-91. 
The Km for puromycin in peptidyl-puromycin 
release from two preparations of E. coli polysomes 
was 3.1-5.2 X 10e6 M, essentially the same as the 
value of 2.4 X 1Om6 M obtained by Pestka [2,3], but 
about two orders of magnitude below Km values 
reported for puromycin with salt-washed ribosomes 
[2,3, 171. Similarly, we have found the Km values 
for puromycin and Pan-L-Phe to be 1.1 X 1 O-4 M and 
1 .O X low4 M, respectively, with washed ribosomes, 
30% methanol and CpApCpCpA(acetyl- [3 H] Leu) as 
donor substrate in the fragment reaction. Limitations 
of solubility and availability prevented the determina- 
tion of fragment reaction Km values for the other 
puromycin analogues, but a more qualitative study of 
their relative reactivities [7] has shown that they 
conform to a hydrophobic hierarchy similar to that 
demonstrated here with polysomes. Thus, polysomes 
appear to have a much higher intrinsic affinity than 
washed ribosomes for all the puromycin analogues. 
The reasons for this difference between polysomes 
and washed ribosomes are not known, although 
Pestka [2] has suggested that the presence of native 
peptidyl-tRNA on the polysome stabilizes a riboso- 
ma1 conformation with increased affinity for puromy- 
tin. Another possibility is that salt washing may re - 
move from polysomes a component which contri- 
butes to puromycin binding. The hypothesis [7] that 
the essential presence of 30% methanol in the frag- 
ment reaction substantially weakens the hydrophobic 
binding of puromycin to the A’-site was not sup- 
ported by the Km values for puromycin which were 
found in the polysome system in the presence and 
absence of 30% methanol to be 7.5 X 10e6 M and 5.2 
X 10e6 M, respectively. Rather, the methanol affected 
the catalysis of the reaction because it caused a three- 
fold decrease in the Vmax (results not shown). Fur- 
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ther evidence that methanol does not reduce the af- 
finity of peptidyl transferase for puromycin is pro- 
vided by the similar Km values determined for puro- 
mycin with washed ribosomes in the fragment reac- 
tion with CpApApCpCpA-(f-Met) as donor substrate 
in the presence of 50% methanol (Km 1.7- 1.9 X 
10m4 M; ref. [2,3]) and in the reaction with acetyl-l- 
Phe-tRNA as donor substrate in the absence of 
methanol (3.1 X 10e4 M; ref. [17]). 
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